Key result
Surgical resection of cardiac myxomas was associated with a 3.8% hospital mortality rate and no recurrences at an average of 80 months postoperatively.
Why the study?
Does surgical resection of cardiac myxoma result in favorable long-term outcomes and low recurrence rates?
Cohort (n=26)
Does surgical resection of cardiac myxoma result in favorable long-term outcomes and low recurrence rates?
Surgical resection of cardiac myxomas is associated with low hospital mortality and excellent long-term outcomes with no recurrence.
Supports resection for myxomas with low mortality here; leaves open confirmation in larger prospective cohorts.
Twenty-six patients have undergone a resection of a cardiac myxoma since 1977. There were five males and 21 females, of age range 14–81 years (mean 50 years). Symptoms included congestive heart failure, emboli, palpitations and syncope. The tumours were located in the left atrium (21 patients), right atrium (four) and right ventricle (one). The hospital mortality rate was 3.8%. Late outcome was known for 24 of 25 (96%) patients. The total follow-up is now 2116 months (mean 88 (range 2-204) months per patient). One patient (4%) died of colonic malignancy 4 years after surgery. Long-term results were satisfactory. Echocardiographic information supporting the absence of recurrence was known for all 23 patients, evaluated at an average of 80 (range 2-196) months postoperatively. Surgical resection is the correct treatment for cardiac myxoma and is imperative following the diagnosis.
No takes yet. Share an insight, caveat, or question.
Bastos et al. (1995) conducted a cohort in Cardiac myxoma (n=26). Surgical resection was evaluated on Hospital mortality. Surgical resection of cardiac myxomas was associated with a 3.8% hospital mortality rate and no recurrences at an average of 80 months postoperatively.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: